• Mashup Score: 1
    NRG-BR008: HERO - 9 month(s) ago

    Currently Available for Patients About This Study NRG-BR008, also known as the “HERO” trial, is a clinical study trying to determine if treatment with HER2-targeted therapy without radiation therapy is as good as the usual treatment of HER2-targeted therapy with radiation in patients with early-stage…

    Tweet Tweets with this article
    • When a HERO comes along With the strength to carry on You cast your fears aside And you know you can survive The NRG-BR008 "HERO" radiation therapy omission study patient website live: https://t.co/N01v5o2YuZ (don't worry #radonc residents; results long ways off)

  • Mashup Score: 1
    Protocol - 9 month(s) ago

    EAY191-N2: Phase 2 Trial of Fulvestrant and Binimetinib in Patients With Hormone Receptor-Positive Metastatic Breast Cancer With a Frameshift or Nonsense Mutation or Genomic Deletion in NF1 Principal Investigator Bora Lim, MD Status Open to Accrual …

    Tweet Tweets with this article
    • RT @naborala: Protocol fully open for accrual - let us know if your tumor has NF1 mutation: https://t.co/tshCOwSmj7

  • Mashup Score: 3

    About This Study FORTE study is led by NRG Oncology and is a part of the National Clinical Trials Network (NCTN) program, which is sponsored by the National Cancer Institute (NCI). FORTE is a colorectal cancer prevention study looking to determine how often participants who have had 1-2 small benign polyps removed during colonoscopy from their colon otherwise known as adenomatous…

    Tweet Tweets with this article
    • RT @fortestudy: Learn more about our study by visiting our website: https://t.co/1H3mmswM7b #clinicaltrials #clinicalresearch #cancer #co…

  • Mashup Score: 0

    The four Non-Disease Site Committees conduct NRG Oncology trials as well as support research within the disease site committees. Annual Call for NRG Oncology Committee Member Applications  Are you interested in serving on an NRG Oncology committee? NRG Oncology depends on its members to advance its mission. Our members help drive our research, develop protocols, contribute to our science, and…

    Tweet Tweets with this article
    • NRG > Committees & Programs > Non-Disease Site Scientific Committees Many opportunities for ⁦@NRGonc⁩ committee memberships https://t.co/iCUlXOLaIe

  • Mashup Score: 16
    Protocol - 2 year(s) ago

    Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy For Limited Metastatic Non-Small Cell Lung Cancer (NSCLC):  A Randomized Phase II/III Trial Principal Investigator Puneeth Iyengar, MD PhD Status Temporarily Closed to Accrual …

    Tweet Tweets with this article
    • How is it that the radiation oncologist running one of the most important phase III trials in our field has <1,000 followers? #radonc https://t.co/AKImTgWbgp https://t.co/B3fjUWWFcQ

  • Mashup Score: 3

    How to register: Click on the link: Register Here  (The link will take you to the registration portal). The password that auto generates is for the registration portal only! You must register first to select your sessions in the CONNECT portal. Please note: If you want to attend the 2 symposiums, you must select and pay in full during…

    Tweet Tweets with this article
    • RT @TGeorgeMD: GI Committee meetings today are OPEN. Hop in if interested in learning more https://t.co/0VhmAd6H3F @NRGonc @TedHong9 @s…

  • Mashup Score: 3

    How to register: Click on the link: Register Here  (The link will take you to the registration portal). The password that auto generates is for the registration portal only! You must register first to select your sessions in the CONNECT portal. Please note: If you want to attend the 2 symposiums, you must select and pay in full during…

    Tweet Tweets with this article
    • GI Committee meetings today are OPEN. Hop in if interested in learning more https://t.co/0VhmAd6H3F @NRGonc @TedHong9 @skopetz @ILSONDavid #NRG2022 https://t.co/veZkcXGUky